Foresite Capital Management II as of Sept. 30, 2021
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 4 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| 10x Genomics Class A Common (TXG) | 90.7 | $255M | 1.8M | 145.58 | |
| Novavax (NVAX) | 5.0 | $14M | 67k | 207.31 | |
| Acceleron Pharma | 2.8 | $7.9M | 46k | 172.11 | |
| Epizyme | 1.5 | $4.3M | 832k | 5.12 |
